Related Experiment Videos
Botulinum toxin in the treatment of cerebral palsy
1University Institute of Clinical Neurophysiology, University Medical Centre, Ljubljana, Slovenia.
Insights
Botulinum toxin A effectively improved skilled movements and foot posture in children with cerebral palsy. This safe treatment offered significant functional gains with minimal, temporary side effects.
Area of Science:
- Neurology
- Pediatrics
- Rehabilitation Medicine
Background:
- Cerebral palsy often causes dynamic limb deformities and muscle tone abnormalities.
- Dystonic limb posture significantly impairs skilled movements and functional abilities in affected children.
Purpose of the Study:
- To evaluate the efficacy of botulinum toxin A in treating dystonic skilled movements and gait disorders in children with cerebral palsy.
- To assess improvements in functional disability and limb posture following botulinum toxin A treatment.
Main Methods:
- A cohort of 13 children with cerebral palsy received botulinum toxin A injections.
- Treatment targeted dynamic deformities and muscle tone changes of corticospinal and extrapyramidal origin.
- Functional outcomes, including skilled hand movements and foot posture, were assessed post-treatment.
Main Results:
- Botulinum toxin A treatment resulted in significant improvements in functional disability (p < 0.01).
- Improvements were observed in skilled hand movements and foot posture.
- The mean duration of therapeutic effect was 3.1 months, with negligible and transient side effects like muscle weakness.
Conclusions:
- Botulinum toxin A is a safe and effective adjuvant therapy for dystonic skilled movements in children with cerebral palsy.
- The treatment significantly enhances functional abilities and gait in pediatric patients with cerebral palsy.
- Further research can explore long-term outcomes and optimal dosing strategies.
Abstract:
This paper reports the results of botulinum toxin A treatment in 13 children with cerebral palsy. All patients except one exhibited dynamic deformities in one hand or foot and changes in muscle tone of corticospinal and extrapyramidal origin. The primary purpose of the treatment was to improve the impaired skilled movements which resulted from dystonic limb posture and were the most disabling symptoms in the group studied. The study showed that the botulinum toxin treatment produced a significant improvement in functional disability in terms of amelioration of skilled hand movements and foot posture (p < 0.01). The injections took effect a few days after dystonic muscle infiltration, and the mean duration of improvement was 3.1 months (2.0-4.0 months). Side effects were negligible and transient; transitory muscle weakness was the most frequent. Botulinum toxin A provides a safe and effective adjuvant treatment of dystonic skilled movements and gait disorders in children with cerebral palsy.